PHARMACOECONOMIC EVALUATION OF ABIRATERONE ACETATE VERSUS CABAZITAXEL IN THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN KAZAKHSTAN

被引：1
|
作者：
Kostyuk, A. [1 ]
Almadiyeva, A. [1 ]
机构：
[1] Natl Ctr Hlth Dev, Astana, Kazakhstan
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.513
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A412 / A412
页数：1
相关论文
共 50 条
  • [21] Activity of cabazitaxel following docetaxel and abiraterone acetate in patients with castration-resistant prostate cancer.
    Sella, Avishay
    Sella, Tal
    Peer, Avivit
    Berger, Raanan
    Frank, Stephen Jay
    Gez, Eliahu
    Sharid, David
    Hayat, Henry
    Rosenbaum, Eli
    Neiman, Victoria
    Keizman, Daniel
    Kovel, Svetlana
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] Abiraterone Acetate, A Novel Adrenal Inhibitor in Metastatic Castration-Resistant Prostate Cancer
    Salem, Mohamed
    Garcia, Jorge A.
    [J]. CURRENT ONCOLOGY REPORTS, 2011, 13 (02) : 92 - 96
  • [23] Cabazitaxel for the treatment of castration-resistant prostate cancer
    Agarwal, Neeraj
    Sonpavde, Guru
    Sartor, Oliver
    [J]. FUTURE ONCOLOGY, 2011, 7 (01) : 15 - 24
  • [24] Abiraterone Acetate, A Novel Adrenal Inhibitor in Metastatic Castration-Resistant Prostate Cancer
    Mohamed Salem
    Jorge A. Garcia
    [J]. Current Oncology Reports, 2011, 13 : 92 - 96
  • [25] Cardiovascular safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients: a prospective evaluation
    Prati, Veronica
    Ruatta, Fiorella
    Aversa, Caterina
    Gernone, Angela
    Galizia, Danilo
    Bonzano, Alessandro
    Torino, Sofia
    Nuzzolese, Imperia
    Marandino, Laura
    Aglietta, Massimo
    Ortega, Cinzia
    [J]. FUTURE ONCOLOGY, 2018, 14 (05) : 443 - 448
  • [26] Abiraterone Acetate: A Guide to Its Use in Metastatic Castration-Resistant Prostate Cancer
    Lesley J. Scott
    Lily P. H. Yang
    Katherine A. Lyseng-Williamson
    [J]. Drugs & Aging, 2012, 29 : 243 - 248
  • [27] Abiraterone acetate to treat metastatic castration-resistant prostate cancer in combination with prednisone
    Duarte, C.
    Jimeno, A.
    Kessler, E. R.
    [J]. DRUGS OF TODAY, 2019, 55 (01) : 5 - 15
  • [28] Abiraterone acetate: a promising drug for the treatment of castration-resistant prostate cancer
    Agarwal, Neeraj
    Hutson, Thomas E.
    Vogelzang, Nicholas J.
    Sonpavde, Guru
    [J]. FUTURE ONCOLOGY, 2010, 6 (05) : 665 - 679
  • [29] The development of abiraterone acetate for castration-resistant prostate cancer
    Grist, Emily
    Attard, Gerhardt
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (06) : 289 - 294
  • [30] Combination therapy with olaparib and abiraterone acetate for metastatic castration-resistant prostate cancer
    Martini, Alberto
    Fallara, Giuseppe
    Ploussard, Guillaume
    Malavaud, Bernard
    [J]. LANCET ONCOLOGY, 2023, 24 (10): : 1056 - 1057
12345